We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Risk of Severe COVID-19-Related Outcomes among Patients with Cirrhosis: A Population-Based Cohort Study in Canada.
- Authors
Velásquez García, Héctor Alexander; Adu, Prince A.; Okonkwo-Dappa, Ada; Makuza, Jean Damascene; Cua, Georgine; Binka, Mawuena; Wilton, James; Sbihi, Hind; Janjua, Naveed Z.
- Abstract
We assessed the association between cirrhosis and severe COVID-19-related outcomes among people with laboratory-diagnosed COVID-19 infection in British Columbia, Canada. We used data from the British Columbia (BC) COVID-19 Cohort, a population-based cohort that integrates data on all individuals tested for COVID-19, with data on hospitalizations, medical visits, emergency room visits, prescription drugs, chronic conditions, and deaths in the Canadian province of BC. We included all individuals aged ≥18 who tested positive for SARS-CoV-2 by real-time reverse transcription-polymerase chain reaction from 1 January 2021 to 31 December 2021. Multivariable logistic regression models were used to assess the associations of cirrhosis status with COVID-19-related hospitalization and with ICU admission. Of the 162,509 individuals who tested positive for SARS-CoV-2 and were included in the analysis, 768 (0.5%) had cirrhosis. In the multivariable models, cirrhosis was associated with increased odds of hospitalization (aOR = 1.97, 95% CI: 1.58–2.47) and ICU admission (aOR = 3.33, 95% CI: 2.56–4.35). In the analyses stratified by age, we found that the increased odds of ICU admission among people with cirrhosis were present in all the assessed age-groups. Cirrhosis is associated with increased odds of hospitalization and ICU admission among COVID-19 patients.
- Subjects
BRITISH Columbia; CANADA; EMERGENCY room visits; CIRRHOSIS of the liver; DRUGS; COHORT analysis; COVID-19
- Publication
Viruses (1999-4915), 2024, Vol 16, Issue 3, p351
- ISSN
1999-4915
- Publication type
Article
- DOI
10.3390/v16030351